Statins in primary biliary cirrhosis: Are they safe?

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 2086-2088

  Rajab, Murad Abu ^a   Kaplan, Marshall M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Hepatotoxicity; Primary biliary cirrhosis; Statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; CHOLESTEROL; COLCHICINE; EZETIMIBE; FLUINDOSTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILIARY CIRRHOSIS; CHOLESTEROL BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PRIORITY JOURNAL;

AGED; ALANINE TRANSAMINASE; ANTICHOLESTEREMIC AGENTS; AZETIDINES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAFETY MANAGEMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954424607     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0988-9     Document Type: Article

References (12)

1. MM Kaplan ME Gershwin 2005 Primary biliary cirrhosis N Engl J Med 353 1261 1273 10.1056/NEJMra043898 1:CAS:528:DC%2BD2MXhtVeltLbI 16177252 (Pubitemid 41345948)
2. M Longo A Crosignani PM Battezzati, et al. 2002 Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis Gut 51 265 269 10.1136/gut.51.2.265 1:STN:280:DC%2BD38znt1Wquw%3D%3D 12117892 (Pubitemid 34791459)
3. N Chalasani H Aljadhey J Kesterson MD Murray SD Hall 2004 Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity Gastroenterology 126 1287 1292 10.1053/j.gastro.2004.02.015 1:CAS:528: DC%2BD2cXksF2qtLw%3D 15131789 (Pubitemid 38552793)
4. R Vuppalanchi N Chalasani 2006 Statins for hyperlipidemia in patients with chronic liver disease: are they safe? Clin Gastroenterol Hepatol 4 838 839 10.1016/j.cgh.2006.04.020 16829348 (Pubitemid 43994543)
5. S Khorashadi NK Hasson RC Cheung 2006 Incidence of statin hepatotoxicity in patients with hepatitis C Clin Gastroenterol Hepatol 4 902 907 10.1016/j.cgh.2006.03.014 1:CAS:528:DC%2BD28XotFars7w%3D 16697272 (Pubitemid 43994535)
6. CM Stanca N Bach J Allina C Bodian H Bodenheimer Jr JA Odin 2008 Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis Dig Dis Sci 53 1988 1993 10.1007/s10620-007-0003-2 1:CAS:528:DC%2BD1cXmtlynsLk%3D 18392679
7. T Stojakovic C Putz-Bankuti G Fauler, et al. 2007 Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid Hepatology 46 776 784 10.1002/hep.21741 1:CAS:528:DC%2BD2sXhtFWhsrrJ 17668874 (Pubitemid 47436124)
8. U Ritzel U Leonhardt M Nather G Schafer VW Armstrong G Ramadori 2002 Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers J Hepatol 36 454 458 10.1016/S0168-8278(02)00006-5 1:CAS:528:DC%2BD38XksFaru7g%3D 11943414 (Pubitemid 34407331)
9. JH Lewis ME Mortensen S Zweig, et al. 2007 Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial Hepatology 46 1453 1463 10.1002/hep.21848 1:CAS:528:DC%2BD2sXhtlOiu7bM 17668878 (Pubitemid 350155527)
10. S Tuteja NT Pyrsopoulos WR Wolowich, et al. 2008 Simvastatin-ezetimibe- induced hepatic failure necessitating liver transplantation Pharmacotherapy 28 1188 1193 10.1592/phco.28.9.1188 18752389
11. CE Jahn EJ Schaefer LA Taam, et al. 1985 Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification Gastroenterology 89 1266 1278 1:STN:280:DyaL28%2FjtFWisA%3D%3D 4054519
12. SM Grundy GL Vega A Garg 1990 Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia Am J Cardiol 66 31B 38B 10.1016/0002-9149(90)90438-7 1:CAS:528:DyaK3MXlsFSqsQ%3D%3D 2206034